Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Chemours

How a major chemical company is moving into the future while reckoning with a dangerous legacy

Does the world's tech present—and future—require PFAS?

Fortune

Despite 3M’s phase-out, problem of cleaning up PFAS remains

3M announced in mid-December that it's phasing out a family of harmful chemicals, but they're not going away.

Tribune News Service

PFAS left dangerous blood compounds in nearly all US study participants

The toxic ‘forever chemicals’ can stay in human blood for years, and are linked to cancers, kidney damage and heart disease

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

High levels of ‘forever chemicals’ likely making alligators sick in Cape Fear River

Cape Fear River alligators’ blood showed much higher PFAS levels, and had twice as many compounds, as those in neighboring river

The Guardian - US

Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022

Upgrades

Benzinga

Cancer fears plague residents of US region polluted by ‘forever chemicals’

Exposure to harmful PFAS remains almost impossible to escape – particularly for the people of the Cape Fear River basin

The Guardian - US

‘Forever chemical’ response may push costs to water utilities

WASHINGTON — Federal efforts to address pollution by so-called forever chemicals may push increased costs onto water and wastewater agencies.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

'Forever chemical' response may push costs to water utilities - Roll Call

Federal efforts to address pollution by so-called forever chemicals may push increased costs onto water and wastewater agencies.

Roll Call

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022

Upgrades

Benzinga

Analyst Ratings for Chemours

Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter:

Benzinga

Expert Ratings for Chemours

Within the last quarter, Chemours (NYSE:CC) has observed the following analyst ratings:

Benzinga

Chemours: Q1 Earnings Insights

Chemours (NYSE:CC) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by 58.7%, reporting an EPS of $1.46 versus an estimate of $0.92.

Benzinga

Scientists sound alarm at US regulator’s new ‘forever chemicals’ definition

Narrower definition excludes chemicals in pharmaceuticals and pesticides that are generally defined as PFAS

The Guardian - US

Chemours: Q4 Earnings Insights

Chemours (NYSE:CC) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours missed estimated earnings by 11.96%, reporting an EPS of $0.81 versus an estimate of $0.92.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Teflon’s River of Fear

Chemical giant Chemours is facing off against residents of North Carolina in a battle over a potentially harmful compound used to make nonstick pans.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.